The parasitic protozoan, Trypanosoma brucei, is the causative agent of sleeping sickness in humans and nagana in domestic livestock. Sleeping sickness is invariably fatal if left untreated. Current drugs are ineffective and toxic, and drug resistance is on the rise, highlighting the importance of identifying novel drug targets. In T. brucei mitochondria, post-transcriptional RNA editing is required for the creation of translatable mRNAs. Editing is an essential process in both the procyclic insect vector stage (PF) and the bloodstream mammalian host stage (BF) life cycle stages. Thus, proteins involved in RNA editing are promising targets for chemotherapeutic attack. The RNA binding protein, RBP16, is an essential multi-functional gene regulatory protein that acts as an RNA editing accessory factor for CYb mRNA, as well as stabilizing several never-edited mitochondrial RNAs, in PF T. brucei. RBP16 is modified by methylation on several arginine residues, and this modification is important for its macromolecular interactions and gene regulatory functions in PF. In T. brucei, mitochondrial gene expression is dramatically regulated between PF and BF life cycle stages. RBP16 is relatively abundant in BF stage that infects humans;however, nothing is known about its role in mitochondrial gene regulation in this stage of the parasite. In this application, we will examine the role of RBP16 in BF T. brucei mitochondrial gene regulation using RNAi-mediated down-regulation. We will determine the effect of RBP16 depletion on both RNA editing and stabilization in BF. We will analyze RBP16 protein-protein and protein-RNA interactions in BF using immunoprecipitation and gradient sedimentation analyses. Finally, we will determine the roles of two major protein arginine methyltransferases in RBP16 methylation and macromolecular interactions in BF T. brucei. Our hypothesis is that RBP16 regulates the editing and/or abundance of specific mitochondrial mRNA in BFs, distinct from those it affects in PFs. Furthermore, we propose that RBP16 does so in conjunction with additional mitochondrial proteins and that these protein-protein interactions may be impacted by protein arginine methylation.

Public Health Relevance

Together, the proposed studies will greatly expand the understanding of both mitochondrial gene regulation and the functions of arginine methylation in the human infectious form of T. brucei.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
5F32AI077185-02
Application #
7940852
Study Section
Special Emphasis Panel (ZRG1-F13-C (20))
Program Officer
Mcgugan, Glen C
Project Start
2009-09-01
Project End
2011-08-31
Budget Start
2010-09-01
Budget End
2011-08-31
Support Year
2
Fiscal Year
2010
Total Cost
$53,810
Indirect Cost
Name
State University of New York at Buffalo
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
038633251
City
Buffalo
State
NY
Country
United States
Zip Code
14260
Fisk, John C; Zurita-Lopez, Cecilia; Sayegh, Joyce et al. (2010) TbPRMT6 is a type I protein arginine methyltransferase that contributes to cytokinesis in Trypanosoma brucei. Eukaryot Cell 9:866-77